rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 750 participants.
Also called NCT07606807
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 750 participants
- Registry
-
NCT07606807
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07606807. Randomized; single masking; primary purpose treatment. Start 2026-08-01 (anticipated); primary completion 2028-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window
- Acronym
- SIMPLIFIED
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Tenecteplase (rhTNK-tPA) (0.25 mg/kg, to maximum of 25mg)
- Intervention (Drug)
- Standard medical treatment
- Lead sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Record details
- Record id
cardio:ct-nct07606807- Content hash
9fe74d78d22ee817800f22e8b01337b8c4a380e70531ef408f582aeaf2872886